Hudson Bay Capital Management LP Trimmed Bristol Myers Squibb Co (BMY) Holding, Magellan Health (MGLN) Covered By 3 Bulls

July 14, 2017 - By Adrian Erickson

Among 4 analysts covering Magellan Health (NASDAQ:MGLN), 3 have Buy rating, 1 Sell and 0 Hold. Therefore 75% are positive. Magellan Health had 14 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Friday, July 14 by KeyBanc Capital Markets. The firm earned “Buy” rating on Monday, September 26 by Jefferies. Barclays Capital downgraded the shares of MGLN in report on Wednesday, January 6 to “Underweight” rating. Leerink Swann maintained the stock with “Buy” rating in Friday, June 23 report. The firm has “Buy” rating given on Friday, May 20 by Jefferies. Barclays Capital maintained the stock with “Underweight” rating in Wednesday, November 23 report. Scotia Capital maintained Magellan Health Inc (NASDAQ:MGLN) rating on Tuesday, August 11. Scotia Capital has “Sector Perform” rating and $10 target. Jefferies maintained the shares of MGLN in report on Wednesday, June 7 with “Buy” rating. See Magellan Health Inc (NASDAQ:MGLN) latest ratings:

14/07/2017 Broker: KeyBanc Capital Markets Old Rating: Sector Weight New Rating: Overweight Upgrade
23/06/2017 Broker: Leerink Swann Rating: Buy New Target: $73.0000 Maintain
07/06/2017 Broker: Jefferies Rating: Buy New Target: $88.0000 Maintain

Hudson Bay Capital Management Lp decreased Bristol Myers Squibb Co (BMY) stake by 85.91% reported in 2016Q4 SEC filing. Hudson Bay Capital Management Lp sold 230,939 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Hudson Bay Capital Management Lp holds 37,886 shares with $2.21 million value, down from 268,825 last quarter. Bristol Myers Squibb Co now has $90.15 billion valuation. The stock rose 0.77% or $0.42 reaching $55.09. About 3.26M shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since July 14, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.16, from 1.13 in 2016Q3. It dropped, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. 1.14 billion shares or 1.92% more from 1.12 billion shares in 2016Q3 were reported. Comerica Commercial Bank stated it has 0.29% in Bristol-Myers Squibb Co (NYSE:BMY). Moreover, Janus Cap Mgmt Llc has 0.97% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 19.82M shares. Parasol Investment Mngmt Ltd Liability Company invested 0.24% in Bristol-Myers Squibb Co (NYSE:BMY). First In accumulated 12,390 shares or 0.43% of the stock. Blue Chip Ptnrs invested in 2,124 shares or 0.05% of the stock. Grantham Mayo Van Otterloo Ltd Liability Co owns 3,500 shares for 0% of their portfolio. Banque Pictet And Cie Sa owns 0.1% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 66,450 shares. Barrington Strategic Wealth Management Limited Liability Corp stated it has 16,855 shares. Cwm Ltd Limited Liability Company holds 0.33% or 91,965 shares in its portfolio. Ipswich Inv Mgmt Com has 0.78% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 29,542 shares. Davis R M Inc holds 0.08% or 29,407 shares. Commonwealth Ltd Liability Corporation reported 0.02% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Alliancebernstein LP holds 0.15% or 3.17 million shares. Ronald Blue Limited Liability reported 9,589 shares stake. Haverford Tru accumulated 77,094 shares.

Hudson Bay Capital Management Lp increased Whiting Petroleum Corp (NYSE:WLL) stake by 93,714 shares to 154,964 valued at $1.86 million in 2016Q4. It also upped Sherwin Williams Stk (NYSE:SHW) stake by 3,358 shares and now owns 6,308 shares. Barrick Gold Corp (Call) was raised too.

Analysts await Bristol-Myers Squibb Co (NYSE:BMY) to report earnings on July, 27. They expect $0.73 earnings per share, up 5.80% or $0.04 from last year’s $0.69 per share. BMY’s profit will be $1.19B for 18.87 P/E if the $0.73 EPS becomes a reality. After $0.84 actual earnings per share reported by Bristol-Myers Squibb Co for the previous quarter, Wall Street now forecasts -13.10% negative EPS growth.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 4 Sell and 8 Hold. Therefore 37% are positive. Bristol-Myers Squibb Company had 40 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was downgraded by Berenberg on Thursday, August 11 to “Hold”. Hilliard Lyons initiated Bristol-Myers Squibb Co (NYSE:BMY) on Monday, May 23 with “Neutral” rating. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Buy” rating by UBS on Friday, April 29. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Equal-Weight” rating by Morgan Stanley on Friday, August 5. BMO Capital Markets maintained the shares of BMY in report on Wednesday, April 5 with “Market Perform” rating. Berenberg upgraded the stock to “Buy” rating in Friday, January 22 report. Deutsche Bank maintained it with “Hold” rating and $52 target in Friday, October 28 report. The rating was initiated by Robert W. Baird with “Outperform” on Wednesday, April 26. The firm has “Equal Weight” rating given on Friday, April 29 by Barclays Capital. The rating was maintained by Barclays Capital with “Equal-Weight” on Friday, September 9.

Since February 27, 2017, it had 1 insider buy, and 6 sales for $9.91 million activity. $1.91M worth of Bristol-Myers Squibb Co (NYSE:BMY) was sold by ANDREOTTI LAMBERTO. The insider Caldarella Joseph C sold $463,779. The insider LEUNG SANDRA sold $5.27 million. Samuels Theodore R. II bought $681,240 worth of stock. 5,000 shares were sold by Schmukler Louis S, worth $282,470 on Friday, March 17.

Investors sentiment increased to 0.97 in 2016 Q4. Its up 0.06, from 0.91 in 2016Q3. It increased, as 14 investors sold Magellan Health Inc shares while 81 reduced holdings. 40 funds opened positions while 52 raised stakes. 21.43 million shares or 3.41% more from 20.72 million shares in 2016Q3 were reported. Aqr Capital Management Ltd holds 0.01% in Magellan Health Inc (NASDAQ:MGLN) or 49,752 shares. Employees Retirement System Of Texas stated it has 11,000 shares or 0.01% of all its holdings. 164,011 were accumulated by Smith Graham And Com Inv L P. 1.09M were accumulated by Renaissance Tech Lc. Moreover, Arizona State Retirement System has 0.01% invested in Magellan Health Inc (NASDAQ:MGLN). Amalgamated Natl Bank holds 3,106 shares or 0.01% of its portfolio. 14 are owned by Parkside Retail Bank And Trust. Thrivent For Lutherans holds 0.04% or 121,780 shares in its portfolio. Systematic Limited Partnership, a New Jersey-based fund reported 58,990 shares. Oxford Asset Management, a United Kingdom-based fund reported 33,243 shares. Bnp Paribas Arbitrage holds 0% or 5,919 shares in its portfolio. Zacks Invest Mngmt has invested 0.09% in Magellan Health Inc (NASDAQ:MGLN). Panagora Asset Mgmt holds 0.02% of its portfolio in Magellan Health Inc (NASDAQ:MGLN) for 71,736 shares. Prelude Capital Mgmt Lc holds 0.03% or 3,233 shares in its portfolio. Quantbot Techs Limited Partnership stated it has 0.07% in Magellan Health Inc (NASDAQ:MGLN).

Magellan Health, Inc. is engaged in the healthcare management business. The company has market cap of $2.01 billion. The Company’s divisions include Healthcare, Pharmacy Management and Corporate. It has a 23.12 P/E ratio. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare.

About 85,560 shares traded. Magellan Health Inc (NASDAQ:MGLN) has risen 5.31% since July 14, 2016 and is uptrending. It has underperformed by 11.39% the S&P500.